Comprehensive notes on Speroff 2019: Regulation of the Menstrual Cycle
Regulation of the Menstrual Cycle
Overview: Menstrual cycle is governed by dynamic hypothalamic–pituitary–gonadal (HPG) hormone interactions with autocrine–paracrine ovarian signaling. Modern understanding emphasizes the three phases: follicular phase, ovulation, and luteal phase, and how ovarian and pituitary hormones coordinate to produce a normal rhythmic cycle.
Key concept: The cycle is orchestrated by hormone changes that align morphologic and autocrine–paracrine ovarian events with central (hypothalamic/pituitary) signaling. This coordination is among the most remarkable biological processes.
Practical implication: Understanding normal regulation is essential for diagnosing and managing abnormal menstrual function.
The Follicular Phase
Objective: A cohort of follicles is recruited; most undergo atresia, with a single dominant follicle ultimately destined for ovulation.
Timeline: Recruitment and selection occur over roughly 10–14 days (cycle-dependent; exact timing varies).
Follicular recruitment and dominance
The ovary contains a large primordial follicle pool at birth; growth proceeds despite pregnancy, ovulation, or anovulation.
Primordial follicle: oocyte arrested in diplotene; single layer of cuboidal granulosa cells; follicles undergo atresia unless rescued by FSH during luteal–follicular transition.
Oocyte-granulosa autocrine–paracrine communication via gap junctions coordinates growth and maturation (see below).
Initial follicle growth spans multiple cycles; only a minority reach preovulatory status in a given cycle.
The size of the residual primordial pool influences how many follicles begin growth each cycle. Reducing the pool (e.g., unilateral oophorectomy) redistributes follicle availability over time.
The first follicle that responds to stimulation may gain an early lead and never relinquish it, but the cohort generally competes to determine the dominant follicle.
Molecular signals initiating primordial follicle formation and early growth
Local factors in the ovary include TGF-β family members and neurotrophins (NGF, BDNF, NT-3, NT-4/5).
AMH inhibits primordial follicle growth; BMPs promote growth. Activins promote growth; inhibins retard growth.
Oocyte-produced GDF9 and BMP15 are crucial for normal follicle development; FOXL2 is essential for granulosa cell differentiation.
Gap junctions (connexins; GJAs) enable exchange of nutrients, ions, cAMP, and small signaling molecules between granulosa cells and the oocyte. Gap junctions are regulated: FSH opens/closes channels to coordinate growth; LH closes some pathways after ovulation.
Two-cell, two-gonadotropin system (establishing estrogen production in the follicle)
Theca interna cells express LH receptors; LH stimulates theca to produce androgens.
Granulosa cells express FSH receptors; FSH stimulates aromatase (P450arom) to convert androgens to estrogens.
The two-cell, two-gonadotropin model is the central mechanism for estrogen production in preantral and antral follicles.
The theca and granulosa compartments interact; aromatization is enhanced as granulosa cells mature and gain LH receptor expression late in follicular development.
Growth factors and intraovarian regulation
Activin, inhibin, AMH, BMPs modulate FSH action within the follicle and regulate LH receptor formation.
GDF9 and BMP15 from the oocyte are crucial for normal folliculogenesis; knockout models show infertility with impaired follicle development.
FOXL2 is essential for granulosa cell differentiation; FOXL2 mutations cause premature ovarian failure.
Oocyte–granulosa bidirectional signaling involves paracrine factors (e.g., GDF9, BMP15) and gap junction communication to support metabolism and growth.
Gap junctions and oocyte energy metabolism
Gap junctions allow exchange of ions (e.g., Ca2+), metabolites (pyruvate), amino acids (L-alanine), cholesterol, and signaling molecules (e.g., cAMP) between granulosa cells and the oocyte.
In mouse models, connexin deletions disrupt follicle/oocyte development; granulosa cells metabolize glucose to pyruvate to support oocyte energy needs.
Hormonal programs during early follicular development
FSH “rescues” follicles from atresia during the luteal–follicular transition; persistence and duration of the FSH rise are critical.
Androgens in the follicle act as substrates for estrogen production but can be limiting or inhibitory when in excess (see Fig. 5.2 concept); aromatization is favored in estrogen-dominant microenvironments.
Estrogen production and feedback in the follicular phase
Early follicular estrogen production is aided by FSH and LH-driven theca androgen supply; granulosa aromatase activity converts androgens to estradiol.
Rising intrafollicular estrogen elevates FSH receptor expression and estrogen within the follicle promotes a local autocrine amplification of its own growth.
Estradiol also exerts negative feedback at the hypothalamic–pituitary level to taper FSH and promote selection of a dominant follicle.
Inhibins, activins, and follistatin in folliculogenesis
Inhibins (A and B) are secreted by granulosa cells; they inhibit FSH secretion by the pituitary.
Activins stimulate FSH release and may enhance follicle sensitivity to FSH; follistatin binds activin and dampens its action.
The balance of inhibin–activin–follistatin shapes the FSH milieu and follicular responsiveness across the cycle.
Anti-Müllerian hormone (AMH) and follicle recruitment
AMH is produced by granulosa cells of growing follicles; it inhibits primordial follicle growth and reduces the rate of recruitment.
AMH levels reflect the number of growing follicles and ovarian aging; AMH is relatively cycle-independent but can be affected by hormonal contraception.
AMH helps regulate the size of the growing follicle pool and is a marker of ovarian reserve.
Insulin-like growth factors (IGFs) in the ovary
IGF-I and IGF-II act locally in the ovary; IGF-I is liver-derived and supports growth hormone actions; IGF-II is abundant in human follicles.
IGFs promote granulosa and theca cell proliferation, steroidogenesis, and aromatase activity; IGF signaling interacts with FSH and LH to enhance follicular development.
IGF-binding proteins (IGFBPs 1–6) regulate IGF bioavailability and actions within the follicle; pattern of IGFBP expression changes with follicle development and cycle phase.
Growth factors and angiogenesis
VEGF (vascular endothelial growth factor) is central to follicular angiogenesis; LH stimulates VEGF production in granulosa cells and luteal VEGF drives corpus luteum vascularization.
Angiopoietins (Ang-1 and Ang-2) regulate vessel maturation and stability via the Tie-2 receptor; dynamic balance is essential for follicular growth and luteal function.
Other growth factors include EGF family members (amphiregulin, epiregulin, betacellulin) that mediate LH-induced signaling necessary for cumulus expansion and oocyte maturation.
The dominant follicle and follicular wave dynamics
The dominant follicle emerges as estrogen levels rise locally; the dominant follicle acquires more FSH receptors and robust aromatase activity, sustaining growth despite declining systemic FSH.
The wave of atresia among lesser follicles parallels rising estrogen, which downregulates FSH via negative feedback.
By day ~9 of the cycle, the dominant follicle’s theca vasculature is twice that of other antral follicles, allowing preferential gonadotropin delivery and continued FSH responsiveness.
Estrogen receptors and local estrogen action
In the primate ovary, estrogen receptors are mainly ER-β (not ER-α) in granulosa cells and oocytes, supporting local roles for estrogen in follicular and luteal growth.
Estrogen acts locally and systemically to shape follicular development and pituitary–hypothalamic feedback.
GnRH and pulsatile gonadotropin secretion
GnRH pulses drive the secretion of FSH and LH; amplitude and frequency are modulated by ovarian steroids.
Follicular phase: GnRH pulses are more frequent and of smaller amplitude; near ovulation, pulses increase in amplitude and FSH/LH rise.
Mid-cycle estrogen positive feedback on LH (and possibly FSH) depends on sustained estradiol elevations (>200 pg/mL for ~50 hours) and the follicle reaching ~15 mm diameter.
Diurnal patterns exist: FSH shows circadian rhythm throughout the cycle; LH shows nocturnal decline, especially in the luteal phase.
The Preovulatory Follicle and the LH Surge
The dominant follicle transitions to a preovulatory state under the combined influence of estrogen and FSH, with LH receptors accumulating on granulosa cells under estrogen’s influence.
Preovulatory events and estrogen–LH axis
The dominant follicle reaches a state where its estrogen production is sufficient to trigger the LH surge via positive feedback mechanisms at the pituitary and possibly hypothalamus.
The LH surge initiates luteinization of granulosa cells and progesterone production; it also promotes follicular rupture through coupling with prostaglandins and growth factors.
Progesterone and estrogen interplay around the LH surge
Progesterone increases within the follicle prior to ovulation, facilitated by LH; this supports positive feedback and luteinization.
The dominant follicle’s progesterone receptor expression increases in response to LH signaling, and progesterone helps modulate granulosa cell mitosis and LH receptor function.
Local paracrine/autocrine regulation during the preovulatory interval
LH-induced signaling engages EGF-like factors (amphiregulin, epiregulin, betacellulin) to propagate the ovulatory cascade within the follicle.
Prostaglandins (PGE2 and PGF2α), leukocytes, cytokines (IL-1β, TNF-α), and plasminogen activators coordinate rupture of the follicular wall (the stigma).
Proteolytic enzymes (MMPs) and their inhibitors (TIMPs) are tightly regulated; LH and progesterone shift balance toward proteolysis at ovulation.
The role of androgens and sexuality around ovulation
Midcycle androgens rise from the theca as estrogen production surges; this local rise may support estrogen synthesis and potentially influence libido enhancements around ovulation.
Oocyte maturation and cumulus expansion
LH surge, via downstream signaling, promotes resumption of meiosis in the oocyte and cumulus expansion through EGF-like signaling pathways and prostaglandins.
Omi (oocyte maturation inhibitor) and nitric oxide help regulate premature resumption of meiosis; LH surge overrides these controls to permit maturation.
Timing of ovulation
Ovulation occurs roughly 10–12 hours after the LH peak and about 24–36 hours after peak estradiol levels.
The LH surge itself lasts about 48–50 hours, with full oocyte maturation and rupture requiring a threshold LH exposure of 14–27 hours.
Spontaneous LH surges in humans often occur in the early morning hours; ovulation timing varies with diurnal and seasonal patterns, and right-sided ovulation appears somewhat more common.
The Luteal Phase
Corpus luteum formation and function
After ovulation, granulosa cells luteinize to form the corpus luteum (CL); the theca interna may contribute theca lutein cells.
The luteal phase features rapid luteinization, angiogenesis, and robust progesterone production; estrogen production also continues and is LH-dependent in the primate CL.
The CL is highly vascularized and contains steroidogenic and non-steroidogenic cell components, including endothelial cells, leukocytes, and fibroblasts.
Hormonal milieu and luteal maintenance
Continuous, tonic LH (and LH-like hCG if pregnancy occurs) supports CL function and steroidogenesis (Progesterone and estrogen production).
Progesterone rises rapidly after ovulation, peaking around day 8–9 post-ovulation in many cycles; estradiol also rises and the two hormones coordinate endometrial receptivity.
Inhibin A rises in the late follicular phase and midluteal phase, contributing to FSH suppression during the luteal phase; Inhibin B dominates the follicular phase.
Angiogenesis and luteolysis
VEGF-driven angiogenesis supports the early luteal vascularization and steroidogenesis; it is subsequently modulated by angiopoietins (Ang-1 and Ang-2).
As luteolysis approaches, VEGF and Ang-1 decline; Ang-2 signaling increases, promoting vascular breakdown and luteolysis.
Prostaglandins and luteolysis
Prostaglandin F2α (PGF2α) is a key luteolytic mediator in nonprimates and contributes to luteal regression in primates via endothelin-1 and other pathways.
hCG rescue in pregnancy maintains CL function by increasing TIMPs (tissue inhibitors of metalloproteinases) and limiting MMP-driven luteolysis.
The luteal-follicular transition and midcycle suppression
Luteolysis is opposed by hCG rescue in pregnancy; in non-pregnant cycles, the CL regresses around days 9–11 post-ovulation, and menses begins with withdrawal of luteal hormones.
The transition from luteal to follicular phase involves decreasing estradiol, progesterone, and inhibin A; GnRH pulse frequency increases, driving rises in FSH relative to LH for the next cycle.
Endocrine–paracrine interactions in the CL
Gap junctions and endothelial cells facilitate signal exchange within the CL; oxytocin has paracrine effects within the CL; immune cells contribute cytokines and remodeling enzymes during luteolysis.
Luteolysis and resumption of the cycle
Luteolysis involves proteolytic enzyme activity (MMPs) and a shift in angiogenic signaling toward breakdown; timing and regulation are complex and involve local factors (activin, inhibin, follistatin) and systemic cues.
Pregnancy and corpus luteum rescue
If pregnancy occurs, the blastocyst secretes hCG early (days 7–8 post-fertilization) to rescue the CL, maintaining luteal function until placental steroidogenesis is established.
Rescue maintains luteal vasculature and steroidogenesis; hCG can also influence ovarian immune and growth factor signaling during early pregnancy.
The Luteal-Follicular Transition
Critical timing window after the luteal decline and before the next follicular wave
Menstrual cycle resumes with menses signaling the end of one cycle and the recruitment of follicles for the next.
Two major hormonal changes initiate a new cycle: rapid withdrawal of luteal hormones (estradiol, progesterone, inhibins) and a selective rise in FSH beginning around 2 days before menses.
Mechanisms driving the transition
Decrease in inhibin A releases pituitary suppression on FSH; estradiol and progesterone declines reduce negative feedback and allow GnRH pulsatility to increase.
GnRH pulsatility shifts to favor a greater rise in FSH relative to LH, initiating a new wave of follicular recruitment.
Inhibin B rises after FSH stimulates granulosa cells, serving as a late-phase feedback signal to suppress FSH as the wave progresses.
GnRH–gonadotropin dynamics during transition
The luteal–follicular transition features a marked increase in GnRH pulse frequency and, consequently, increased FSH relative to LH secretion.
Activin enhances GnRH receptor formation and pituitary FSH synthesis; inhibin and follistatin modulate this axis by balancing activin signaling.
Clinical relevance
This transition explains the observed rise in FSH bioactivity just before menses and the initiation of a new follicular cohort.
The FSH increase is essential for rescuing ~70 days-worth of primordial follicles from atresia and beginning a new cycle of follicular growth.
The Normal Menstrual Cycle: Length, Variability, and Age Effects
Cycle length is determined by follicular growth rate and development timing; it varies among individuals and across life stages.
Typical patterns and age-related changes
Menarche is followed by several years of relatively long cycles that gradually become more regular as puberty progresses.
In the late 30s, cycle length variability reduces (shorter and more regular cycles) due to subtle changes in FSH, inhibin, and follicle dynamics.
About 2–4 years before menopause, cycle length increases again as ovarian reserve declines and cycle regularity diminishes.
By age 37–38, the primordial follicle pool is decreased and the rate of follicular loss accelerates, contributing to perimenopause.
Follicle dynamics and aging
The total follicle pool and the variability in cycle length are affected by age, BMI, and body composition: both high and low BMI can lengthen cycles.
The number of antral follicles decreases with age, reflected by shifting levels of inhibins, activins, and AMH.
The luteal phase and stability
The luteal phase is relatively consistent in length (about 11–17 days is considered normal); most cycles are 24–35 days long.
Short luteal phases occur in ~5–6% of cycles and contribute to cycle variability.
Menopause and cycle cessation
Declining follicle numbers lead to eventual anovulation and cessation of reproductive cycling; menopause occurs when ovarian follicle reserves are exhausted.
Sperm Transport, Fertilization, Implantation, and Early Embryogenesis (Introduction to Conceptual Framework)
Historical context: The study of fertilization has advanced from early discoveries by Leeuwenhoek and Hertwig to modern assisted reproductive technologies (ART) including IVF.
Sperm maturation and capacitation
In mammals, sperm mature in the epididymis (caput, corpus, cauda) and gain fertilizing ability during epididymal transit and capacitation in the female reproductive tract.
Capacitation is the final functional maturation step that enables sperm to undergo acrosome reaction and fertilize the oocyte.
Epididymal maturation timeline
Sperm reach the caudal epididymis about 72 days after initiation of spermatogenesis; this maturation process equips sperm with fertilizing capabilities.
The oocyte and surrounding structures
The oocyte completes meiosis II upon fertilization, forming the second polar body and haploid pronuclei.
The cumulus oophorus and zona pellucida are critical for sperm binding and acrosome reaction.
Fertilization and early embryogenesis (conceptual framework)
Successful fertilization requires capacitation, acrosome reaction, sperm–egg fusion, and oocyte activation.
After fertilization, the zygote undergoes cleavage divisions and forms a blastocyst, which implants into the endometrium around days 6–7 post-ovulation in a typical cycle.
Early embryogenesis involves genome activation and the beginning of placental development, with the initial reliance on luteal progesterone support until placental steroidogenesis is established.
Integrated clinical relevance
Disruptions at any stage—from follicular development and LH surge timing to luteal support or endometrial receptivity—can lead to infertility.
Understanding the hormonal cascades and the cellular/molecular players helps optimize ART protocols (e.g., timing of gonadotropin administration, follicle monitoring, luteal-phase support).
Key Formulas, Numbers, and Thresholds (LaTeX notation)
Estrogen positive feedback threshold for LH surge:
LH surge duration:
Dominant follicle diameter at LH surge onset:
Dominant follicle estrogen receptor maturation and receptor density: FSH receptor density reaches ~
Preovulatory interval timing: Ovulation ≈ LH peak + 10–12 hours; peak estradiol precedes ovulation by ~24–36 hours.
Preovulatory progesterone rise and LH-driven luteinization: Progesterone production increases in periovulatory period; LH receptor expression on granulosa cells facilitates progesterone synthesis.
Luteal phase duration in humans:
Sperm maturation timeline in humans: Sperm reach cauda epididymis after ≈ of spermatogenesis;
General cycle length ranges and typical patterns: cycles commonly range from about to days; luteal phase is relatively constant (~11–17 days) across cycles.
Notes on terminology and units:
AMH = anti-Müllerian hormone; acts to limit primordial follicle recruitment and reflects follicle pool size.
VEGF = vascular endothelial growth factor; essential for follicular and corpus luteum angiogenesis.
GDF9, BMP15 = oocyte-derived growth factors crucial for granulosa cell function and follicle development.
TNF-α, IL-1β = inflammatory cytokines involved in ovulation and luteolysis processes.
Connections to Foundational Principles and Real-World Relevance
Endocrine–paracrine integration: The cycle illustrates how endocrine hormones (GnRH, FSH, LH, estrogens, progesterone) interact with intraovarian autocrine/paracrine signals (activin/inhibin, AMH, GDF9, BMP15) to regulate cellular behavior and tissue remodeling.
Two-cell, two-gonadotropin model: A foundational concept explaining estrogen production in the follicle via theca-derived androgens converted to estrogens by granulosa cells under LH and FSH control.
Feedback loops: Negative feedback of estrogen and inhibin on FSH, and the positive feedback of estrogen on LH during midcycle; dynamic pulsatility of GnRH drives the rhythmic secretion of FSH and LH.
Clinical implications: Understanding the regulation of the normal cycle informs management of infertility, uses of ovarian stimulation in IVF, and treatment of menstrual disorders. Age- and BMI-related changes illustrate how cycle physiology shifts with ovarian reserve and metabolic state.
Sperm–egg biology and implantation: The introductory section to conception emphasizes the cascade from sperm maturation to capacitation, fertilization, and early embryogenesis, tying ovarian physiology to successful conception.
If you want, I can tailor these notes further into exam-focused bullet points (e.g., concise “high-yield” facts, common diagram labels, or a quick-reference checklist for each phase).